Milner Institute partners with Flagship Pioneering and CUHP to accelerate biotech research and innovation
The Milner Therapeutics Institute are delighted to announce a new collaboration with Flagship Pioneering and Cambridge University Health Partners (CUHP), to jointly advance breakthrough scientific research and technologies.
Milner Therapeutics Institute announces 2025 Consortium Call
The 2025 Milner Therapeutics Consortium Call opened on 13 January, with an exciting new focus around pharma-led challenges.
Milner Therapeutics Institute joins Cambridge-ARIA collaboration to create new technologies for transforming brain health
The Milner Therapeutics Institute (MTI) has joined a three-year collaboration with the science funding agency ARIA and multiple Cambridge partners.
Milner Institute celebrates success of 2024 Pitch Day and Therapeutics Symposium
The Milner Therapeutics Institute were delighted to host two sell-out events in Cambridge that brought academics, investors, pharma and biotech companies together.
Milner Therapeutics Institute Director Professor Tony Kouzarides awarded a knighthood in King's Birthday Honours List
Professor Tony Kouzarides, Director of the Milner Therapeutics Institute, has been awarded a knighthood for services to healthcare innovation and delivery.
Milner Therapeutics Institute to house world-class functional genomics laboratory, in new partnership with AstraZeneca and the Medical Research Council
The University of Cambridge announces a new partnership with AstraZeneca and the Medical Research Council (MRC) that will establish a new state-of-the-art functional genomics laboratory at the Milner Therapeutics Institute.
Takeda and Sanofi join Milner Therapeutics Consortium
The Milner Therapeutics Institute are excited to announce that two new pharma partners — Takeda and Sanofi — have joined the Milner Consortium in the past month.
A full house at eighth Milner Therapeutics Symposium
The Milner Therapeutics Institute celebrates the success of its eight annual Symposium, held at West Road Concert Hall on 5th July.
Dr Cathy Tralau-Stewart appointed Executive Director of the Milner Therapeutics Institute
The Milner Therapeutics Institute are delighted to welcome Dr Cathy Tralau-Stewart as our new Executive Director.